Sign in
WithdrawnPhase 2

Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma Exacerbations

Key facts

Who runs it
Queen Mary University of London
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Phase
Phase 2
Started
27 Mar 2025
Ended
1 Apr 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • FloMask - reuseable face mask
Record updated
20 May 2025
Why it stopped
Diminished minimum sample size needed to detect any effect of the intervention due to TwiCs study design, control arm participants were already recruited to the parent study (COVIDENCE UK).

Who can take part

Age
16 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Aged 16 or more years
  • Doctor diagnosis of asthma
  • Current prescription for treatment of asthma
  • Participant in COVIDENCE UK nasal swab study
  • Age 16 or more
  • Living in same household as index participant who has consented to take part in trial

Who cannot take part

  • Regularly using any FFP-rated face mask when in an indoor public place
  • Currently sharing household with one or more children
  • Currently sharing household with one or more other COVIDENCE UK participants who have asthma
  • Unable to tolerate wearing face mask; Eligibility criteria, household members of index participants:
  • Unable to tolerate wearing face mask

Other criteria

  • Eligibility criteria, participants with asthma ('index participants'):

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

REMASK trial is a Trial within Cohort study (TwiCs), nested within the COVIDENCE UK longitudinal study. It has been designed to determine whether the offer of a free reusable, elastomeric face mask to adults with asthma and other members of their household reduces risk of RT-PCR confirmed viral respiratory infections and asthma exacerbations.

The 2 groups in the trial

  • InterventionTreatment being tested

    Offer of free reusable elastometic face mask and 12-month supply of replaceable filters to index participants with asthma and their adult household members

    Treatment: FloMask - reuseable face mask

  • ControlNo study treatment, for comparison

    Usual asthma care without offer of intervention above

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Reuseable Face Masks to Reduce Risk of Viral Respiratory Infections and Exacerbations in Adults With Asthma: a Randomised Controlled Trial
Record updated
20 May 2025